Kamada-alpha-1-antitrypsin

alpha-1 antitrypsin inhalation · Kamada Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kamada-alpha-1-antitrypsin, covering 2020-01-18 to 2020-01-18. Get the full timeline:

Most recent: Clinical Trial Update: Phase II, Safety and Efficacy Study of Kamada-alpha-1-antitrypsin (AAT) for Inhalation" [Phase 2]